Table 1. Characteristics of Patients Seen During Study Time Periods.
Characteristic | Patients, No. (%) | ||
---|---|---|---|
All patients (n = 23 026) | Time period | ||
Before tablet (n = 12 239) | After tablet (n = 10 787) | ||
Sex | |||
Female | 13 342 (57.9) | 7030 (57.4) | 6312 (58.5) |
Male | 9684 (42.1) | 5209 (42.6) | 4475 (41.5) |
Age, mean (range), y | 59.7 (18-102) | 60.2 (18-102) | 59.0 (18-102) |
Race and ethnicity | |||
Asian | 324 (1.4) | 161 (1.3) | 163 (1.5) |
Black/African American | 3098 (13.5) | 1640 (13.4) | 1458 (13.5) |
Hispanic or Latino | 745 (3.2) | 388 (3.2) | 357 (3.3) |
White, non-Hispanic | 18 542 (80.5) | 9876 (80.7) | 8666 (80.3) |
Othera | 317 (1.4) | 174 (1.4) | 143 (1.3) |
Primary health insurance | |||
Commercial | 10 344 (44.9) | 5382 (44.0) | 4962 (46.0) |
Medicaid | 778 (3.4) | 401 (3.3) | 377 (3.5) |
Medicare | 10 522 (45.7) | 5705 (47.6) | 4817 (44.7) |
Uninsured | 829 (3.6) | 462 (3.8) | 367 (3.4) |
Other | 553 (2.3) | 289 (2.4) | 264 (2.4) |
Practice | |||
A | 3665 (15.9) | 1935 (15.8) | 1730 (16.0) |
B | 3442 (14.9) | 1574 (12.9) | 1868 (17.3) |
C | 3820 (16.6) | 1943 (15.9) | 1877 (17.4) |
Db | 4739 (20.6) | 2866 (23.4) | 1873 (17.4) |
E | 4385 (19.0) | 2215 (18.1) | 2170 (20.1) |
Fb | 2975 (12.9) | 1706 (13.9) | 1269 (11.8) |
Other race and ethnicity categories included American Indian or Alaska Native, Hawaiian or Other Pacific Islander, Other, and Unknown.
The period of observation following implementation at the practice was truncated at 30 days because of the COVID-19 pandemic.